Business Context and Reporting Period
Company: Kimberly-Clark Corporation (KMB)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2025
Business Overview: A global manufacturer of consumer and professional tissue, personal care, and hygiene products. Operations are reported across three segments: North America (NA), International Personal Care (IPC), and International Family Care and Professional (IFP). The company is currently executing a "2024 Transformation Initiative" aimed at cost reduction and supply chain optimization.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $4,840 | $5,149 |
| Gross Profit | $1,733 | $1,911 |
| Gross Margin | 35.8% | 37.1% |
| Operating Profit | $769 | $853 |
| Net Income (Attributable to K-C) | $567 | $647 |
| Diluted EPS | $1.70 | $1.91 |
| Cash Provided by Operations | $327 | $438 |
| Total Debt | $7,247 | $7,443 |
| Cash and Cash Equivalents | $563 | $1,021 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.0% year-over-year. This was driven by unfavorable currency translation (-2.4%), divestitures and business exits (-2.0%), and lower organic sales (-1.6%). Organic sales were impacted by strategic pricing investments.
- Profitability Pressure: Operating profit fell 9.8% to $769 million. Gross margin contracted by 130 basis points, partly due to $53 million in transformation-related charges (workforce reductions and incremental depreciation).
- Segment Performance:
- North America: Sales down 3.9%; Operating profit up 1.3% due to lower SG&A and productivity savings.
- International Personal Care (IPC): Sales down 8.9%; Operating profit down 19.8%, heavily impacted by currency (-6.0%) and pricing.
- International Family Care & Professional (IFP): Sales down 7.7%; Operating profit down 3.6%.
- Liquidity: Cash and cash equivalents dropped from $1.021 billion to $563 million, primarily due to debt repayments ($250 million), dividends ($405 million), and working capital changes.
Guidance, Outlook, and Risks
- Transformation Initiative: The 2024 Transformation Initiative is expected to cost approximately $1.5 billion pre-tax by the end of 2026, with total pre-tax savings of $3.0 billion. Cumulative charges through Q1 2025 were $534 million pre-tax.
- Tariff Impact: New U.S. trade policies announced in April 2025 (10% baseline tariff plus country-specific tariffs) are estimated to incur incremental costs of approximately $300 million in 2025, primarily affecting the North America segment.
- Geopolitical Risks: Operations in Russia (approx. 1-2% of global sales) face continued uncertainty due to the war in Ukraine, including supply chain complexities and sanctions. The company maintains limited essential product sales but has suspended capital investments there.
- Capital Allocation: Full-year capital spending is anticipated to be between $1.0 billion and $1.2 billion. The company repurchased 458,000 shares for $61 million in Q1 2025.
Investor Verification Checklist
- Tariff Mitigation: Verify management's ability to offset the estimated $300 million in incremental tariff costs through pricing or productivity.
- Transformation Execution: Monitor the pace of the $1.5 billion transformation costs and the realization of the projected $3.0 billion in savings.
- Organic Growth: Assess whether the strategic pricing investments will stabilize organic sales growth in subsequent quarters.
- Currency Exposure: Review hedging strategies given the significant negative impact of currency translation on Q1 results (-2.4% on sales).
- Debt Management: Confirm the sustainability of the current debt repayment pace ($250 million in Q1) alongside dividend obligations and capital spending.